A Review: Anti-Dental Plaque Potential of Selected Malaysian Herbs
Keywords:
Oral plaque, Malaysian herbs, and mouthwashAbstract
Dental plaque is a biofilm that forms on the teeth.
Chlorhexidine (CHX) is the most commonly used anti-plaque agent in
mouthwash, and it has been considered the gold standard in dental
practice for around three decades. However, CHX does have some
disadvantages. These disadvantages have led to the search for medicinal
plant based alternative mouthwashes. Herbal products are slowly being
recognized as effective, safe, non-toxic, and having fewer side effects on
humans. The use of herbs as a source of economic growth in Malaysia
has emerged in 2011. This review comprises 11 potential Malaysian herbs
noted for their anti-plaque potential namely, Eurycoma longifolia Jack,
Morinda citrifolia, Centella asiatica, Hibiscus sabdariffa L, Ficus deltoidea
Jack, Zingiber officinale Roscoe, Andrographis paniculata (Burm.f.) Nees,
Orthosiphon stamineus, Clinacanthus nutans Lindau, Melastoma
malabathricum L, and Moringa oleifera Lam. Out of these 11 herbs, 8 have
been identified by the government of Malaysia that can be commercially
developed under first Entry Point Project (EPP1) for the nation’s
agriculture National Key Economic Area (NKEA). The present review
focusses on the traditional use, the valuable phytochemical, anti-plaque
potential and the cytotoxicity of the selected herbs. These information will
serve as a guide for pharmaceutical companies or cosmetic
manufacturers in formulating herbal mouthwashes containing anti-dental
plaque properties of the Malaysian herbs. Further investigations into their
clinical therapeutic potential may be worthwhile.
References
(1) MartÃnez-Hernández M, Reda B, Hannig M. Chlorhexidine rinsing inhibits biofilm formation and causes biofilm disruption on dental enamel in situ. Clinical Oral Investigations. 2020;24:3843-53.
(2) Deus FP, Ouanounou A. Chlorhexidine in dentistry: pharmacology, uses, and adverse effects. International dental journal. 2022;72(3):269-77.
(3) James P, Worthington HV, Parnell C, Harding M, Lamont T, Cheung A, et al. Chlorhexidine mouthrinse as an adjunctive treatment for gingival health. Cochrane Database of Systematic Reviews. 2017(3).
(4) Cieplik F, Jakubovics NS, Buchalla W, Maisch T, Hellwig E, Al-Ahmad A. Resistance toward chlorhexidine in oral bacteria–Is There Cause for Concern? Frontiers in microbiology. 2019;10:587.
(5) Zaki WW, Rani AM. Country status report on medicinal and aromatic plants in Malaysia. Expert consultation on promotion of medicinal and aromatic plants in the Asia-Pacific region: Proceedings. 2013:174.
(6) Bhat R, Karim A. Tongkat Ali (Eurycoma longifolia Jack): a review on its ethnobotany and pharmacological importance. Fitoterapia. 2010;81(7):669-79.
(7) Khanam Z, Wen CS, Bhat IUH. Phytochemical screening and antimicrobial activity of root and stem extracts of wild Eurycoma longifolia Jack (Tongkat Ali). Journal of King Saud University-Science. 2015;27(1):23-30.
(8) Ruan J, Li Z, Zhang Y, Chen Y, Liu M, Han L, et al. Bioactive constituents from the roots of Eurycoma longifolia. Molecules. 2019;24(17):3157.
(9) Moses LB, Abu Bakar MF, Mamat H, Aziz ZA. Unfermented freeze-dried leaf extract of Tongkat Ali (Eurycoma longifolia Jack.) induced cytotoxicity and apoptosis in MDA-MB-231 and MCF-7 breast cancer cell lines. Evidence-Based Complementary and Alternative Medicine. 2021;2021.
(10) Ramzi MI, Kosnin MH, Faisal GG, Arzmi MH, Kusumawardani A, Sabere A, et al. The Effect of Eurycoma Longifolia Jack (Tongkat Ali) Root Extract on salivary S. Mutans, Lactobacillus and Candida Albicans Isolated from High-Risk Caries Adult Patients. Pharmacognosy Journal. 2021;13(3):787-91.
(11) Liu YX, An XL, Xu YN, Hao YJ, Piao XC, Jin MY, et al. Antibacterial and antibiofilm properties of dichloromethane fraction of extracts from adventitious roots of Eurycoma longifolia against Staphylococcus aureus. LWT. 2022;162:113438.
(12) Yaseen MR, Faisal GG, Abd Fuaat A, Affandi KA, Alallam B, Nasir MHM. Preparation of Euyrycoma Longifolia Jack (EL) Tongkat Ali (Ta) Root Extract Hydrogel for Wound Application. Pharmacognosy Journal. 2021;13(6).
(13) Khatun MA, Harun-Or-Rashid M, Rahmatullah M. Scientific validation of eight medicinal plants used in traditional medicinal systems of Malaysia: a review. American-Eurasian Journal of Sustainable Agriculture. 2011;5(1):67-75.
(14) Murthy HN, Joseph KS, Paek KY, Park SY. Production of anthraquinones from cell and organ cultures of Morinda species. Applied Microbiology and Biotechnology. 2023;107(7-8):2061-71.
(15) Zhu H, Zhang J, Li C, Liu S, Wang L. Morinda citrifolia L. leaves extracts obtained by traditional and eco-friendly extraction solvents: Relation between phenolic compositions and biological properties by multivariate analysis. Industrial crops and products. 2020;153:112586.
(16) Palioto G, Silva C, Mendes M, Almeida V, Rocha C, Tonin L. Proximate composition, bioactive compounds and antioxidant activity of fruits of Morinda citrifolia L.(noni) cultivated in Paraná, Brazil. Revista Brasileira de Plantas Medicinais. 2015;17:59-66.
(17) Kumarasamy B, Manipal S, Duraisamy P, Ahmed A, Mohanaganesh S, Jeevika C. Role of aqueous extract of Morinda citrifolia (Indian noni) ripe fruits in inhibiting dental caries-causing Streptococcus mutans and Streptococcus mitis. Journal of Dentistry (Tehran, Iran). 2014;11(6):703.
(18) Pala V, Vishnupriya V, Selvaraj J, Ponnulakshmi R, Gayathri R, Madhan K, et al. Effect of silver nanoparticles synthesized from Morinda citrifolia and irrigants against Streptococcus mutans biofilm. Drug Invention Today. 2019;12(5).
(19) Gu H, Boonanantanasarn K, Kang M, Kim I, Woo KM, Ryoo H-M, et al. Morinda citrifolia leaf extract enhances osteogenic differentiation through activation of wnt/β-catenin signaling. Journal of medicinal food. 2018;21(1):57-69.
(20) Shalan NAAM, Mustapha NM, Mohamed S. Chronic toxicity evaluation of Morinda citrifolia fruit and leaf in mice. Regulatory toxicology and pharmacology. 2017;83:46-53.
(21) Yusof NNM, Rahman TAFTA, A'wani Abd Aziz N, Hadizam BB, Isleih ARIS. Systematic literature review on Centella asiatica. Sains Insani. 2020;5(1):135-41.
(22) Mohapatra P, Ray A, Jena S, Nayak S, Mohanty S. Influence of extraction methods and solvent system on the chemical composition and antioxidant activity of Centella asiatica L. leaves. Biocatalysis and Agricultural Biotechnology. 2021;33:101971.
(23) Talabani AN. An In Vitro Evaluation of the Effectiveness of Gotu Kola (Centella asiatica) on Inhibiting the Growth of Selected Microorganisms in Human Saliva. Journal of Baghdad College of Dentistry. 2016;325(3154):1-5
(24) ShanmugaPriya S, Dineshkumar T, Rajkumar K, Rameshkumar A, Renugalakshmi A, Alzahrani KJ, et al. Evaluating the efficacy of Centella asiatica on enhancement of oral health status in hyperglycemic patients-A randomized clinical trial. Journal of King Saud University-Science. 2023;35(2):102479.
(25) Vasavi H, Arun A, Rekha P. Anti-quorum sensing activity of flavonoid-rich fraction from Centella asiatica L. against Pseudomonas aeruginosa PAO1. Journal of microbiology, immunology and infection. 2016;49(1):8-15.
(26) Riaz G, Chopra R. A review on phytochemistry and therapeutic uses of Hibiscus sabdariffa L. Biomedicine & Pharmacotherapy. 2018;102:575-86.
(27) Sapian S, Ibrahim Mze AA, Jubaidi FF, Mohd Nor NA, Taib IS, Abd Hamid Z, et al. Therapeutic Potential of Hibiscus sabdariffa Linn. in Attenuating Cardiovascular Risk Factors. Pharmaceuticals. 2023;16(6):807.
(28) Bule M, Albelbeisi AH, Nikfar S, Amini M, Abdollahi M. The antidiabetic and antilipidemic effects of Hibiscus sabdariffa: A systematic review and meta-analysis of randomized clinical trials. Food Research International. 2020;130:108980.
(29) Yusrini Djabir Y, Adnan J, Amaliah N, Ramli N, Sartini S, Salang Mamada S, et al. Roselle (Hibiscus sabdariffa L.) calyx water extract ameliorates isoniazid and rifampicin induced liver and renal injuries in rats. Journal of Herbmed Pharmacology. 2021.
(30) Suniarti DF, Suwandi T, Putri SA, Kurnia D. Potential of Hibiscus sabdariffa L. Calyx (Rosella) extract as antibacterial agent in dental disease: Phytochemical and chemical components profiling. Journal of Advanced Pharmaceutical Technology & Research. 2022;13(3):202.
(31) Sulistyani H, Fujita M, Miyakawa H, Nakazawa F. Effect of roselle calyx extract on in vitro viability and biofilm formation ability of oral pathogenic bacteria. Asian Pacific journal of tropical medicine. 2016;9(2):119-24.
(32) Abass AA, Al-Magsoosi MJN, Kadhim WA, Mustafa R, Aljdaimi AI, Al-Nasrawi SJ, et al. Antimicrobial effect of Red Roselle (Hibiscus Sabdariffa) against different types of oral bacteria. Journal of medicine and life. 2022;15(1):89.
(33) Machmud E. Effectiveness of Roselle effervescent tablets as traditional medicinal plants in preventing growth of Candida albicans colonies and Streptococcus mutans. J Contemp Dent Pract. 2018;19(8):925-8.
(34) Baena-Santillán ES, Piloni-Martini J, Rangel-Vargas E, Gómez-Aldapa CA, Sánchez-Gutiérrez M, Madrigal-Santillán EO, et al. Comparison of the Antibacterial Activity and Effect on Membrane Permeability of Hibiscus Acid and a Commercial Chlorhexidine Mouthrinse Against Pathogenic Oral Bacteria and Determination of Hibiscus Acid Toxicity. Journal of Medicinal Food. 2022;25(3):324-8.
(35) Ooi TC, Ibrahim FW, Ahmad S, Chan KM, Leong LM, Mohammad N, et al. Antimutagenic, cytoprotective and antioxidant properties of ficus deltoidea aqueous extract in vitro. Molecules. 2021;26(11):3287.
(36) Bunawan H, Amin NM, Bunawan SN, Baharum SN, Mohd Noor N. Ficus deltoidea Jack: a review on its phytochemical and pharmacological importance. Evidence-Based Complementary and Alternative Medicine. 2014;2014.
(37) Mohd Hanafi M, Alqahtani OSO, Gui L, Yaakob H, Prieto Garcia J. Phytochemical fingerprint and biological activities of three Malaysian Ficus deltoidea cultivars. Journal of Natural Products Discovery. 2022;1(2).
(38) Ashraf K, Haque MR, Amir M, Ahmad N, Ahmad W, Sultan S, et al. An overview of phytochemical and biological activities: Ficus deltoidea Jack and other Ficus spp. Journal of pharmacy & bioallied sciences. 2021;13(1):11.
(39) Azizan N, Mohd Said S, Zainal Abidin Z, Jantan I. Composition and antibacterial activity of the essential oils of Orthosiphon stamineus Benth and Ficus deltoidea Jack against pathogenic oral bacteria. Molecules. 2017;22(12):2135.
(40) Nugroho RA, Aryani R, Manurung H, Rudianto R, Prahastika W, Juwita A, et al. Acute and subchronic toxicity study of the ethanol extracts from Ficus deltoidea leaves in male mice. Open Access Macedonian Journal of Medical Sciences. 2020;8(A):76-83.
(41) Ghasemzadeh A, Jaafar HZ, Karimi E. Involvement of salicylic acid on antioxidant and anticancer properties, anthocyanin production and chalcone synthase activity in ginger (Zingiber officinale Roscoe) varieties. International Journal of Molecular Sciences. 2012;13(11):14828-44.
(42) Zahid NA, Jaafar HZ, Hakiman M. Micropropagation of ginger (Zingiber officinale Roscoe)‘Bentong’and evaluation of its secondary metabolites and antioxidant activities compared with the conventionally propagated plant. Plants. 2021;10(4):630.
(43) Zhang S, Kou X, Zhao H, Mak K-K, Balijepalli MK, Pichika MR. Zingiber officinale var. rubrum: Red ginger’s medicinal uses. Molecules. 2022;27(3):775.
(44) Zaid A, Haw XR, Alkatib HH, Sasidharan S, Marriott PJ, Wong YF. Phytochemical constituents and antiproliferative activities of essential oils from four varieties of Malaysian Zingiber officinale Roscoe against human cervical cancer cell line. Plants. 2022;11(10):1280.
(45) Azizi A, Aghayan S, Zaker S, Shakeri M, Entezari N, Lawaf S. In vitro effect of zingiber officinale extract on growth of Streptococcus mutans and Streptococcus sanguinis. International journal of dentistry. 2015;2015.
(46) Hasan S, Danishuddin M, Khan AU. Inhibitory effect of zingiber officinale towards Streptococcus mutans virulence and caries development: in vitro and in vivo studies. BMC microbiology. 2015;15(1):1-14.
(47) Juariah S, Bakar FIA, Bakar MFA, Endrini S, Kartini S, Ningrum RS. Antibacterial Activity and Inhibition Mechanism of Red Ginger (Zingiber officinale var. rubrum) Ethanol Extract Against Pathogenic Bacteria. Journal of Advanced Research in Applied Sciences and Engineering Technology. 2023;30(1):145-57.
(48) Chopra A, Gayathri R, Vishnu Priya V. Cytotoxic activity of zingiberene on human gingival fibroblast cell lines. Drug Invention Today. 2019;12(3).
(49) Dai Y, Chen S-R, Chai L, Zhao J, Wang Y, Wang Y. Overview of pharmacological activities of Andrographis paniculata and its major compound andrographolide. Critical reviews in food science and nutrition. 2019;59(sup1):S17-S29.
(50) Kumar S, Singh B, Bajpai V. Andrographis paniculata (Burm. f.) Nees: Traditional uses, phytochemistry, pharmacological properties and quality control/quality assurance. Journal of Ethnopharmacology. 2021;275:114054.
(51) Chao W-W, Lin B-F. Isolation and identification of bioactive compounds in Andrographis paniculata (Chuanxinlian). Chinese medicine. 2010;5:1-15.
(52) Alojid AAM, Kub TNT, Miran H, Mohamad S, Tuan TNNTI, Yusoff ME, et al. Antibacterial activity of Andrographis paniculata aqueous extract against oral pathogens. Malaysian Applied Biology. 2021;50(3):163-7.
(53) Nasim I, Jabin Z, Kumar SR, Vishnupriya V. Green synthesis of calcium hydroxide-coated silver nanoparticles using Andrographis paniculata and Ocimum sanctum Linn. leaf extracts: An antimicrobial and cytotoxic activity. Journal of Conservative Dentistry. 2022;25(4):369.
(54) Hussain RM, Razak ZNRA, Saad WMM, Mustakim M. Mechanism of antagonistic effects of Andrographis paniculata methanolic extract against Staphylococcus aureus. Asian Pacific journal of tropical medicine. 2017;10(7):685-95.
(55) Anugrah SM, Rianti D, Agustantina TH. Uji sitotoksisitas ekstrak sambiloto (Andrographis paniculate ness) pada sel fibroblas dengan MTT. Jurnal Material Kedokteran Gigi. 2019;8(2):46-52.
(56) Wang Q, Wang J, Li N, Liu J, Zhou J, Zhuang P, et al. A systematic review of Orthosiphon stamineus Benth. in the treatment of diabetes and its complications. Molecules. 2022;27(2):444.
(57) Ameer OZ, Salman IM, Asmawi MZ, Ibraheem ZO, Yam MF. Orthosiphon stamineus: traditional uses, phytochemistry, pharmacology, and toxicology. Journal of medicinal food. 2012;15(8):678-90.
(58) Khoo LW, Audrey Kow S, Lee MT, Tan CP, Shaari K, Tham CL, et al. A comprehensive review on phytochemistry and pharmacological activities of Clinacanthus nutans (Burm. f.) Lindau. Evidence-Based Complementary and Alternative Medicine. 2018;2018.
(59) Kamarudin MNA, Sarker MMR, Kadir HA, Ming LC. Ethnopharmacological uses, phytochemistry, biological activities, and therapeutic applications of Clinacanthus nutans (Burm. f.) Lindau: A comprehensive review. Journal of ethnopharmacology. 2017;206:245-66.
(60) Teoh PL, Cheng AYF, Liau M, Lem FF, Kaling GP, Chua FN, et al. Chemical composition and cytotoxic properties of Clinacanthus nutans root extracts. Pharmaceutical biology. 2017;55(1):394-401.
(61) Roeslan MO, Ayudhya TDN, Yingyongnarongkul B-e, Koontongkaew S. Anti-biofilm, nitric oxide inhibition and wound healing potential of purpurin-18 phytyl ester isolated from Clinacanthus nutans leaves. Biomedicine & Pharmacotherapy. 2019;113:108724.
(62) Abd Ghafar SA, Fudzi NBAM, Sulaiman WNFW, Hanafiah RM, Lim V. Antibacterial activity of silver nanoparticles Clinacanthus nutans (Agnp-CN) against Streptococcus mutans. International Journal of Research in Pharmaceutical Sciences. 2020;11(4): 1019-24.
(63) Ghazali WASW, Ali NAM, Ponnuraj KT, Mohamad S, Azlina A. Phytochemical analysis and cytotoxicity of Clinacanthus nutans on human gingival fibroblast cell line. Biomedicine. 2022;42(2):241-6.
(64) Zheng W-J, Ren Y-S, Wu M-L, Yang Y-L, Fan Y, Piao X-H, et al. A review of the traditional uses, phytochemistry and biological activities of the Melastoma genus. Journal of Ethnopharmacology. 2021;264:113322.
(65) Diris M, Basri A, Metali F, Ahmad N, Taha H. Phytochemicals and antimicrobial activities of Melastoma malabathricum and Melastoma beccarianum leaf crude extracts. Research Journal of Phytochemistry. 2017;11(1):35-41.
(66) Lestari OA, Palupi NS, Setiyono A, Kusnandar F, Yuliana ND. In vitro antioxidant potential and phytochemical profiling of Melastoma malabathricum leaf water extract. Food Science and Technology. 2022;42.
(67) Hanafiah RM, Abd Ghafar SA, Ibrahim Z, Ahmad WYW, Noor WSAWM, Ibrahim N. Anti-bacterial activities of Melastoma malabathricum stem bark fractions against Streptococcus mutans. Malaysian Journal of Science Health & Technology. 2018;1(1):52-6.
(68) Azizan FF, Hanafiah RM, Msarah MJ, Nor NSM, Ibrahim N, Aqma WS. Antibacterial And Antibiofilm Analyses Of Melastoma Malabathricum Leaves Extract Against Streptococcus Mutans On Tooth Surfaces. Malaysian Journal of Microbiology. 2020;16(6):454-60.
(69) Kamsani N, Zakaria Z, Md Nasir N, Mohtarrudin N, Mohamad Alitheen N. Safety assessment of methanol extract of Melastoma malabathricum L. leaves following the subacute and subchronic oral consumptions in rats and its cytotoxic effect against the HT29 cancer cell line. Evidence-Based Complementary and Alternative Medicine. 2019;2019:1-15.
(70) Konmy BB, Olounladé PA, Azando EBV, Hounzangbé-Adoté SEG. A review on phytochemistry and pharmacology of Moringa oleifera leaves (Moringaceae). Journal of pharmacognosy and phytochemistry. 2016;5(5):325-30.
(71) Padayachee B, Baijnath H. An updated comprehensive review of the medicinal, phytochemical and pharmacological properties of Moringa oleifera. South African Journal of Botany. 2020;129:304-16.
(72) Kandeepan C, Sabitha M, Parvathi K, Senthilkumar N, Ramya S, Boopathi N, et al. Phytochemical Screening, GCMS Profile, and In-silico properties of Bioactive Compounds in Methanolic Leaf Extracts of Moringa oleifera. Journal of Drug Delivery and Therapeutics. 2022;12(2):87-99.
(73) Enerijiofi KE, Akapo FH, Erhabor JO. GC–MS analysis and antibacterial activities of Moringa oleifera leaf extracts on selected clinical bacterial isolates. Bulletin of the National Research Centre. 2021;45(1):1-10.
(74) Elgamily H, Moussa A, Elboraey A, Hoda E-S, Al-Moghazy M, Abdalla A. Microbiological assessment of Moringa oleifera extracts and its incorporation in novel dental remedies against some oral pathogens. Open access Macedonian journal of medical sciences. 2016;4(4):585-90.
(75) Jwa S-K. Efficacy of moringa oleifera leaf extracts against cariogenic biofilm. Preventive Nutrition and Food Science. 2019;24(3):308.
(76) Duarte K, Thomas B, Varma SR, Kamath V, Shetty B, Kuduruthullah S, et al. Antiplaque Efficacy of a Novel Moringa oleifera Dentifrice: A Randomized Clinical Crossover Study. European Journal of Dentistry. 2022;16(4):768-74.
(77) Nugroho JJ, Trilaksana AC, Natsir N, Rovani CA, Hikmah N. Cytotoxicity of 5% ethanol extracts of moringa oleifera leaf as an alternative of root canal irrigant to fibroblast BHK-21 cell culture. Journal of Dentomaxillofacial Science. 2021;6(1):39-41.
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Journal of Biomedical and Clinical Sciences (JBCS)
This work is licensed under a Creative Commons Attribution 4.0 International License.
JBCS Publication Ethics
JBCS is committed to ensure the publication process follows specific academic ethics. Hence, Authors, Reviewers and Editors are required to conform to standards of ethical guidelines.
Authors
Authors should discuss objectively the significance of research work, technical detail and relevant references to enable others to replicate the experiments. JBCS do not accept fraudulent or inaccurate statements that may constitute towards unethical conduct.
Authors should ensure the originality of their works. In cases where the work and/or words of others have been used, appropriate acknowledgements should be made. JBCS do not accept plagiarism in all forms that constitute towards unethical publishing of an article.
This includes simultaneous submission of the same manuscript to more than one journal. Corresponding author is responsible for the full consensus of all co-authors in approving the final version of the paper and its submission for publication.
Reviewers
Reviewers of JBCS treat manuscripts received for review as confidential documents. Therefore, Reviewers must ensure the confidentiality and should not use privileged information and/or ideas obtained through peer review for personal advantage.
Reviews should be conducted based on academic merit and observations should be formulated clearly with supporting arguments. In cases where selected Reviewer feels unqualified to review a manuscript, Reviewer should notify the editor and excuse himself from the review process in TWO (2) weeks time from the review offer is made.
In any reasonable circumstances, Reviewers should not consider to evaluate manuscripts if they have conflicts of interest (i.e: competitive, collaborative and/or other connections with any of the authors, companies, or institutions affiliated to the papers).
Editors
Editors should evaluate manuscripts exclusively based on their academic merit. JBCS strictly do not allow editors to use unpublished information of authors without the written consent of the author. Editors are required to take appropriate responsive actions if ethical complaints have been presented concerning a submitted manuscript or published paper.
CONFLICT OF INTEREST
Journal of Biomedical and Clinical Sciences requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘competing interests section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read ,The authors have declared that no competing interests exist. Editors may ask for further information relating to competing interests.
Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists. Competing interests may be financial or non-financial. A competing interest exists when the authors interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.
HUMAN AND ANIMAL RIGHTS
All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s) institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. Further information and documentation to support this should be made available to Editors on request.
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.
INFORMED CONSENT
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript, this includes to all manuscripts that include details, images, or videos relating to individual participants.
DATA SHARING POLICY
JBCS strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible
Authors who do not wish to share their data must state that data will not be shared, and give the reason.
COPYRIGHT NOTICE
The JBCS retains the copyright of published manuscripts under the terms of the Copyright Transfer Agreement. However, the journal permits unrestricted use, distribution, and reproduction in any medium, provided permission to reuse, distribute and reproduce is obtained from the Journal's Editor and the original work is properly cited.
While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
Copyright (c) 2023 Journal of Biomedical and Clinical Sciences (JBCS)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
